Task: Answer the multiple-choice question.
Question: Which compound exhibits a -25.671% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) COC(=O)c1c(NC(=O)C2CC2)sc2c1CCN(C(C)=O)C2
b.) CCCCCCn1c(CN2CCCCC2CC)nc2c1c(=O)n(C)c(=O)n2C
Answer: a. COC(=O)c1c(NC(=O)C2CC2)sc2c1CCN(C(C)=O)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1c(NC(=O)C2CC2)sc2c1CCN(C(C)=O)C2
COC(=O)c1c(NC(=O)C2CC2)sc2c1CCN(C(C)=O)C2
methyl 6-acetyl-2-(cyclopropanecarbonylamino)-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylate